Skip to Content

Predictive Technology Group Inc PRED

Morningstar Rating
$0.00 0.00 (50.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PRED is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$1.23
Uncertainty
Extreme
1-Star Price
$1.13
5-Star Price
Economic Moat
Fnc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRED is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.04
Bid/Ask
$0.05 / $0.07
Market Cap
$29,959.68
Volume/Avg
100 / 81,553

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
64

Valuation

Metric
PRED
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PRED
Quick Ratio
0.08
Current Ratio
0.29
Interest Coverage
−64.70
Quick Ratio
PRED

Profitability

Metric
PRED
Return on Assets (Normalized)
−32.13%
Return on Equity (Normalized)
−50.64%
Return on Invested Capital (Normalized)
−41.32%
Return on Assets
PRED
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
RvyxdltdVyrz$631.5 Bil
Vertex Pharmaceuticals Inc
VRTX
KsvqddytyQghcy$121.0 Bil
Regeneron Pharmaceuticals Inc
REGN
FcvbjwwlhYlymkk$116.1 Bil
Moderna Inc
MRNA
WglprltMvhfp$51.1 Bil
argenx SE ADR
ARGX
WnkfnhlvSgnm$22.9 Bil
Alnylam Pharmaceuticals Inc
ALNY
QkcjzdvXlyzqg$21.0 Bil
BioNTech SE ADR
BNTX
JsyrrslxVdqz$20.4 Bil
Biomarin Pharmaceutical Inc
BMRN
RrvxcxdfDdqtknk$15.9 Bil
United Therapeutics Corp
UTHR
NbsxqcfGwhg$14.0 Bil
Incyte Corp
INCY
GkfjgdvqwYkppgr$12.5 Bil

Sponsor Center